Nifty
Sensex
:
:
23250.10
76295.36
-82.25 (-0.35%)
-322.08 (-0.42%)

Chemicals

Rating :
N/A

BSE: 542665 | NSE: NEOGEN

2114.30
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  2190.00
  •  2190.00
  •  2106.05
  •  2173.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  65431
  •  1407.61
  •  2420.00
  •  1261.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,330.16
  • 86.59
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,827.17
  • 0.12%
  • 5.43

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.23%
  • 2.09%
  • 13.22%
  • FII
  • DII
  • Others
  • 7.73%
  • 21.61%
  • 4.12%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.46
  • 17.67
  • 12.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.14
  • 13.65
  • 4.91

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.51
  • 4.55
  • -7.22

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 79.56
  • 84.74

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.45
  • 6.90

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 37.64
  • 38.61

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
13.96
22.19
35.42
57.23
P/E Ratio
150.13
94.42
59.17
36.62
Revenue
691
834
1241
1957
EBITDA
110
149
229
392
Net Income
36
58
93
150
ROA
2.8
2.5
2.9
4.7
P/B Ratio
6.87
7.11
6.17
5.44
ROE
5.74
7.42
10.85
15.23
FCFF
-365.24
-591.23
-457.05
-56.83
FCFF Yield
-6.22
-10.07
-7.78
-0.97

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
201.43
164.44
22.49%
193.36
161.71
19.57%
179.95
164.88
9.14%
199.65
203.92
-2.09%
Expenses
166.79
144.15
15.71%
158.85
135.79
16.98%
149.15
136.82
9.01%
163.86
171.33
-4.36%
EBITDA
34.64
20.29
70.72%
34.51
25.92
33.14%
30.80
28.06
9.76%
35.79
32.59
9.82%
EBIDTM
17.20%
12.34%
17.85%
16.03%
17.12%
17.02%
17.93%
15.98%
Other Income
1.06
1.58
-32.91%
0.79
1.89
-58.20%
1.57
1.79
-12.29%
2.21
1.73
27.75%
Interest
13.43
10.52
27.66%
12.75
11.09
14.97%
9.82
10.76
-8.74%
9.69
9.34
3.75%
Depreciation
7.10
5.74
23.69%
7.12
5.79
22.97%
6.81
5.48
24.27%
5.86
4.29
36.60%
PBT
15.17
5.61
170.41%
15.43
10.93
41.17%
15.74
13.61
15.65%
22.45
20.69
8.51%
Tax
5.24
4.64
12.93%
4.52
3.06
47.71%
4.29
3.88
10.57%
5.54
6.40
-13.44%
PAT
9.93
0.97
923.71%
10.91
7.87
38.63%
11.45
9.73
17.68%
16.91
14.29
18.33%
PATM
4.93%
0.59%
5.64%
4.87%
6.36%
5.90%
8.47%
7.01%
EPS
3.79
0.40
847.50%
4.15
3.18
30.50%
4.35
3.91
11.25%
6.42
5.74
11.85%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
774.39
690.67
686.18
487.25
336.41
306.12
239.06
161.15
110.07
100.30
83.92
Net Sales Growth
11.43%
0.65%
40.83%
44.84%
9.89%
28.05%
48.35%
46.41%
9.74%
19.52%
 
Cost Of Goods Sold
427.63
382.48
388.52
274.97
197.63
184.10
140.69
94.83
64.03
61.09
49.74
Gross Profit
346.76
308.19
297.66
212.28
138.78
122.02
98.37
66.32
46.04
39.21
34.18
GP Margin
44.78%
44.62%
43.38%
43.57%
41.25%
39.86%
41.15%
41.15%
41.83%
39.09%
40.73%
Total Expenditure
638.65
580.62
574.56
400.66
272.05
248.07
195.64
132.16
90.08
86.19
71.26
Power & Fuel Cost
-
31.91
33.79
20.30
9.49
8.97
7.64
6.21
5.08
4.94
4.71
% Of Sales
-
4.62%
4.92%
4.17%
2.82%
2.93%
3.20%
3.85%
4.62%
4.93%
5.61%
Employee Cost
-
62.00
46.82
31.50
20.07
17.25
11.15
8.70
5.45
4.54
4.76
% Of Sales
-
8.98%
6.82%
6.46%
5.97%
5.64%
4.66%
5.40%
4.95%
4.53%
5.67%
Manufacturing Exp.
-
56.14
58.96
52.21
32.31
24.91
22.55
15.21
7.86
6.98
5.92
% Of Sales
-
8.13%
8.59%
10.72%
9.60%
8.14%
9.43%
9.44%
7.14%
6.96%
7.05%
General & Admin Exp.
-
23.64
19.79
9.61
6.78
6.96
4.86
2.28
3.81
3.74
3.26
% Of Sales
-
3.42%
2.88%
1.97%
2.02%
2.27%
2.03%
1.41%
3.46%
3.73%
3.88%
Selling & Distn. Exp.
-
17.73
20.27
11.12
5.05
5.20
7.94
4.39
3.21
4.03
2.73
% Of Sales
-
2.57%
2.95%
2.28%
1.50%
1.70%
3.32%
2.72%
2.92%
4.02%
3.25%
Miscellaneous Exp.
-
6.72
6.41
0.95
0.72
0.67
0.80
0.54
0.64
0.88
2.73
% Of Sales
-
0.97%
0.93%
0.19%
0.21%
0.22%
0.33%
0.34%
0.58%
0.88%
0.18%
EBITDA
135.74
110.05
111.62
86.59
64.36
58.05
43.42
28.99
19.99
14.11
12.66
EBITDA Margin
17.53%
15.93%
16.27%
17.77%
19.13%
18.96%
18.16%
17.99%
18.16%
14.07%
15.09%
Other Income
5.63
7.47
4.45
1.07
0.14
0.10
0.51
0.66
0.31
0.16
1.00
Interest
45.69
42.06
28.94
19.08
13.77
11.93
11.94
10.42
7.52
4.79
4.65
Depreciation
26.89
22.87
16.20
11.69
6.90
5.24
2.84
1.85
1.31
1.00
0.94
PBT
68.79
52.59
70.93
56.89
43.83
40.98
29.15
17.39
11.47
8.48
8.06
Tax
19.59
17.12
21.06
12.44
12.88
12.44
8.31
6.44
3.82
3.30
2.98
Tax Rate
28.48%
32.55%
29.69%
21.87%
29.39%
30.36%
28.51%
37.03%
33.30%
38.92%
36.97%
PAT
49.20
35.65
49.97
44.63
31.33
28.54
20.84
10.95
7.64
5.18
5.08
PAT before Minority Interest
49.20
35.65
49.97
44.63
31.33
28.54
20.84
10.95
7.64
5.18
5.08
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
6.35%
5.16%
7.28%
9.16%
9.31%
9.32%
8.72%
6.79%
6.94%
5.16%
6.05%
PAT Growth
49.73%
-28.66%
11.97%
42.45%
9.78%
36.95%
90.32%
43.32%
47.49%
1.97%
 
EPS
18.64
13.50
18.93
16.91
11.87
10.81
7.89
4.15
2.89
1.96
1.92

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
760.29
482.52
439.24
183.01
156.25
70.20
50.41
41.97
27.55
23.49
Share Capital
26.38
24.94
24.94
23.33
23.33
20.08
20.00
20.00
20.00
4.50
Total Reserves
733.91
457.58
414.30
159.68
132.91
50.12
30.41
21.97
7.55
18.99
Non-Current Liabilities
174.13
161.54
141.92
131.01
48.74
59.50
46.42
43.77
7.36
7.27
Secured Loans
124.23
129.08
121.52
116.10
30.36
37.75
22.84
21.84
2.53
3.46
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
12.85
15.65
14.92
2.24
1.27
Long Term Provisions
9.07
4.65
4.04
3.03
3.58
2.02
1.72
1.18
0.24
0.33
Current Liabilities
526.98
409.74
218.27
177.94
149.87
116.74
83.58
66.58
45.58
38.00
Trade Payables
144.60
156.55
98.88
66.08
35.85
42.82
36.67
30.98
21.84
16.36
Other Current Liabilities
135.11
45.15
41.06
23.96
10.50
6.31
4.98
5.17
3.31
3.06
Short Term Borrowings
242.50
204.20
76.20
85.79
101.94
65.17
41.22
30.15
20.06
18.34
Short Term Provisions
4.77
3.84
2.13
2.11
1.58
2.44
0.70
0.28
0.37
0.25
Total Liabilities
1,461.40
1,053.80
799.43
491.96
354.86
246.44
180.41
152.32
80.49
68.76
Net Block
495.62
347.45
285.13
126.71
110.54
82.82
67.05
56.32
17.43
13.19
Gross Block
560.53
389.65
313.41
143.51
120.45
87.51
68.90
59.78
19.58
14.34
Accumulated Depreciation
64.91
42.20
28.28
16.80
9.91
4.69
1.85
3.46
2.15
1.15
Non Current Assets
677.74
397.97
306.97
251.80
123.79
86.67
73.64
62.60
19.57
15.68
Capital Work in Progress
108.91
35.84
10.62
114.65
2.69
0.39
1.38
1.26
0.69
0.13
Non Current Investment
0.45
0.75
0.97
0.75
0.60
0.53
0.42
0.49
0.00
0.00
Long Term Loans & Adv.
69.06
11.18
10.25
9.69
9.95
2.94
2.48
2.27
1.45
2.33
Other Non Current Assets
3.70
2.75
0.00
0.00
0.00
0.00
2.31
2.26
0.00
0.04
Current Assets
783.66
655.83
492.46
240.16
231.06
159.76
106.77
89.72
60.92
53.08
Current Investments
0.00
76.06
80.76
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
382.44
292.97
194.59
114.03
129.87
72.38
49.99
40.01
31.76
24.30
Sundry Debtors
281.69
177.38
109.50
78.55
75.23
60.66
41.36
32.16
15.85
17.97
Cash & Bank
12.49
20.70
45.22
1.21
1.48
2.02
1.82
3.08
2.47
2.40
Other Current Assets
107.04
5.96
7.97
3.61
24.48
24.70
13.60
14.47
10.83
8.40
Short Term Loans & Adv.
98.02
82.76
54.42
42.76
21.52
22.30
13.04
1.95
1.54
2.20
Net Current Assets
256.68
246.09
274.19
62.22
81.19
43.02
23.20
23.14
15.34
15.07
Total Assets
1,461.40
1,053.80
799.43
491.96
354.85
246.43
180.41
152.32
80.49
68.76

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
-29.15
-30.35
1.41
83.57
-34.55
-3.68
11.85
0.21
8.59
8.65
PBT
52.77
71.03
57.07
44.21
41.10
29.25
17.43
11.51
8.48
8.06
Adjustment
56.58
46.04
24.22
13.14
22.16
14.92
11.83
7.54
6.09
5.17
Changes in Working Capital
-128.75
-135.90
-70.08
36.59
-85.07
-42.34
-13.40
-14.94
-2.83
-2.03
Cash after chg. in Working capital
-19.40
-18.83
11.21
93.94
-21.81
1.83
15.85
4.11
11.74
11.20
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-9.75
-11.52
-9.80
-10.37
-12.74
-5.51
-4.00
-3.90
-3.15
-2.55
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-215.58
-94.46
-145.83
-134.57
-28.63
-20.09
-12.68
-32.92
-4.41
-1.79
Net Fixed Assets
-36.34
-101.46
-65.87
-135.02
-35.24
-17.62
-9.24
-40.77
-5.80
0.13
Net Investments
51.82
4.70
-80.76
0.00
0.00
0.00
0.00
-0.45
0.00
0.00
Others
-231.06
2.30
0.80
0.45
6.61
-2.47
-3.44
8.30
1.39
-1.92
Cash from Financing Activity
236.53
100.29
188.43
50.73
62.64
23.97
-0.43
33.32
-4.11
-6.25
Net Cash Inflow / Outflow
-8.20
-24.52
44.01
-0.27
-0.54
0.20
-1.26
0.61
0.07
0.61
Opening Cash & Equivalents
20.70
45.22
1.21
1.48
2.02
1.82
3.08
2.47
2.40
1.79
Closing Cash & Equivalent
12.50
20.70
45.22
1.21
1.48
2.02
1.82
3.08
2.47
2.40

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
288.21
193.47
176.12
78.44
66.96
34.96
25.21
20.98
13.77
52.19
ROA
2.83%
5.39%
6.91%
7.40%
9.49%
9.77%
6.58%
6.57%
6.94%
7.72%
ROE
5.74%
10.84%
14.34%
18.47%
25.21%
34.56%
23.70%
22.00%
20.30%
23.61%
ROCE
9.49%
13.25%
14.33%
16.75%
21.88%
25.46%
22.82%
23.01%
26.11%
27.42%
Fixed Asset Turnover
1.45
1.95
2.13
3.04
3.34
3.27
2.55
3.06
6.42
6.33
Receivable days
121.30
76.30
70.43
70.02
71.35
72.86
81.81
72.13
56.68
68.93
Inventory Days
178.47
129.67
115.59
111.05
106.19
87.39
100.15
107.83
93.95
90.82
Payable days
143.69
119.98
109.49
94.13
55.38
74.63
92.30
110.77
84.02
84.47
Cash Conversion Cycle
156.08
85.99
76.54
86.94
122.15
85.63
89.66
69.20
66.61
75.28
Total Debt/Equity
0.52
0.75
0.51
1.18
0.88
1.71
1.63
1.65
0.96
1.03
Interest Cover
2.25
3.45
3.99
4.21
4.44
3.44
2.67
2.53
2.77
2.73

News Update:


  • Neogen Chemicals gets nod to invest 20 million JPY in NCL Japan
    26th Mar 2025, 12:15 PM

    Board has approved execution of Share subscription agreement between the company and NCL Japan

    Read More
  • Neogen Chemicals - Quarterly Results
    1st Feb 2025, 19:39 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.